Hydrogen-rich saline attenuates chemotherapy-induced ovarian injury via regulation of oxidative stress

作者: XIAOYIN MENG , HONGGUANG CHEN , GUOLIN WANG , YONGHAO YU , KELIANG XIE

DOI: 10.3892/ETM.2015.2787

关键词:

摘要: Hydrogen has been reported to exert a therapeutic effect in several diseases due its antioxidative, anti-inflammatory and anti-apoptotic properties. The aim of the present study was investigate whether hydrogen-rich saline treatment could attenuate ovarian damage induced by cisplatin. A total 240 adult, virgin, female Sprague Dawley rats, weighing 180-220 g, were randomly divided into four groups (n=60 per group): Control (Con), control + (Con H2), cisplatin-induced injury (OI) (OI H2). Cisplatin diluted immediately before use. In OI H2 groups, rats administered dose cisplatin on 1st 7th days. Con intraperitoneally injected with (10ml/kg body weight) once day over 2-week period. On 14th, 28th 42nd days (T1, T2 T3) after injection, femoral vein blood collected. At end experiment, homogenates prepared, samples used for estrogen (E2), follicle-stimulating hormone (FSH), superoxide dismutase (SOD), catalase (CAT) malondialdehyde (MDA) examination. addition, (n=10 group) sacrificed bilateral ovary removal; one fixed formalin follicle-counting analysis, while other nuclear factor erythroid 2-related 2 (Nrf2) detection western blotting. Hydrogen-rich attenuated FSH release, elevated level E2, improved development follicles, reduced cortex at T1, T3 rats. oxidative stress increasing levels oxidation products attenuating activity antioxidant enzyme, which be reversed treatment. Furthermore, regulated Nrf2 protein expression damage. conclusion, exerts protective against reducing MDA SOD CAT activity. Ovarian chemotherapy involves activation Nrf2.

参考文章(32)
Y Saitoh, N Miwa, Y Yoshimura, K Nakano, Platinum nanocolloid-supplemented hydrogendissolved water inhibits growth of human tongue carcinoma cells preferentially over normal cells. Experimental Oncology. ,vol. 31, pp. 156- 162 ,(2009)
Kentaro Hayashida, Motoaki Sano, Ikuroh Ohsawa, Ken Shinmura, Kayoko Tamaki, Kensuke Kimura, Jin Endo, Takaharu Katayama, Akio Kawamura, Shun Kohsaka, Shinji Makino, Shigeo Ohta, Satoshi Ogawa, Keiichi Fukuda, Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochemical and Biophysical Research Communications. ,vol. 373, pp. 30- 35 ,(2008) , 10.1016/J.BBRC.2008.05.165
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, M. J. Thun, Cancer statistics, 2007. CA: A Cancer Journal for Clinicians. ,vol. 57, pp. 43- 66 ,(2007) , 10.3322/CANJCLIN.57.1.43
Truyen Nguyen, Chung S. Yang, Cecil B. Pickett, The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress Free Radical Biology and Medicine. ,vol. 37, pp. 433- 441 ,(2004) , 10.1016/J.FREERADBIOMED.2004.04.033
Yi Zhang, Yan Cheng, Xingcong Ren, Li Zhang, Kai Lee Yap, Hao Wu, Rajesh Patel, David Liu, Zheng-Hong Qin, Ie-Ming Shih, Jin-Ming Yang, NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response Oncogene. ,vol. 31, pp. 1055- 1064 ,(2012) , 10.1038/ONC.2011.290
Martin M. Matzuk, Lianna Dionne, Qiuxia Guo, T. Rajendra Kumar, Russell M. Lebovitz, Ovarian Function in Superoxide Dismutase 1 and 2 Knockout Mice Endocrinology. ,vol. 139, pp. 4008- 4011 ,(1998) , 10.1210/ENDO.139.9.6289
Victoria L. Bae-Jump, Chunxiao Zhou, John F. Boggess, Paola A. Gehrig, Synergistic effect of rapamycin and cisplatin in endometrial cancer cells. Cancer. ,vol. 115, pp. 3887- 3896 ,(2009) , 10.1002/CNCR.24431
Jimmy Belotte, Nicole M. Fletcher, Awoniyi O. Awonuga, Mitchell Alexis, Husam M. Abu-Soud, Mohammed G. Saed, Michael P. Diamond, Ghassan M. Saed, The Role of Oxidative Stress in the Development of Cisplatin Resistance in Epithelial Ovarian Cancer Reproductive Sciences. ,vol. 21, pp. 503- 508 ,(2014) , 10.1177/1933719113503403
Stephanie Morgan, Federica Lopes, Charlie Gourley, Richard A. Anderson, Norah Spears, Cisplatin and Doxorubicin Induce Distinct Mechanisms of Ovarian Follicle Loss; Imatinib Provides Selective Protection Only against Cisplatin PLoS ONE. ,vol. 8, pp. e70117- ,(2013) , 10.1371/JOURNAL.PONE.0070117